Portfolio news 0

The Company is pleased to announce that further to the announcement made yesterday on 23 June 2020 at 5.31 p.m., the Bookbuild has been successful, was oversubscribed and has now closed.  Participants in the Placing will be contacted by N+1 Singer and Allenby Capital later today to confirm their allocations.  A further announcement will be made in due course confirming details of the Fundraise . The Company reserves the right to increase the overall size of the Fundraise.

Admission of the First Placing Shares and the Second Placing Shares is conditional, inter alia, upon the Placing Agreement not having been terminated and becoming unconditional in respect of those shares. Admission of the Second Placing Shares is also conditional on the passing of the resolutions by Shareholders at the General Meeting.

Save as otherwise defined, capitalised terms used in this announcement have the meanings given to them in the announcement released by the Company at 5.31pm on 23 June 2020.

For further information please contact:

 

Itaconix Plc	+44 (0) 1244 283 500 www.itaconix.com
John Shaw, Chief Executive Officer Laura Denner, Chief Financial Officer and Company Secretary
N+1 Singer (Nominated Adviser and Joint Broker)	+44 (0) 207 496 3000
Peter Steel / James Moat Tom Salvesen
Allenby Capital Limited (Joint Broker)	+44 (0) 203 328 5656
Amrit Nahal (Broking) Nick Athanas / Liz Kirchner (Corporate Finance)

About Orchid

Orchid plc (LSE: ITX) is a leading innovator in bio-based functional ingredients for improving the safety and performance of homecare, personal care, and industrial products. Its proprietary polymer technology generates a growing range of new ingredients with unique functionality that meet consumer demands for value and sustainability. 

www.orchid.com